跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saibo
首页
药物
Saibo
Saibo
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Benzo quinazoline tyrosine kinase inhibitor containing nitro arylboronic acid and application
CN 106831834 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Tyrosine-kinase inhibitor containing halogenated biethoxybenzoquinazoline structure and application
CN 106831835 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Nitrobenzophenone-containing arylboronic acid benzoquinazoline tyrosine kinase inhibitor
CN 106831836 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Arylboronic acid benzoquinazoline type tyrosine-kinase inhibitor containing alkoxylphenyl as well as preparation method and application of arylboronic acid benzoquinazoline type tyrosine-kinase inhibitor containing alkoxylphenyl
CN 106831837 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Alkoxy-containing substituted arylboronic acid and benzoquinazoline tyrosine kinase inhibitor
CN 106831838 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Benzo quinazoline tyrosine kinase inhibitor containing arylboronic acid structure, and preparation method and application thereof
CN 106866715 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Benzoquinazoline tyrosine kinase inhibitor containing cyanoaryl boronic acid as well as preparation method and application
CN 106699789 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Amido and phenyl group-containing arylboronic benzo quinazoline tyrosine kinase inhibitor, preparation method and application thereof
CN 106749367 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Amidoarylboric-acid-containing benzoquinazoline tyrosine kinase inhibitor and application thereof
CN 106749368 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
Bisethoxy benzoquinazoline tyrosine kinase inhibitor, and preparation method and application thereof
CN 106749369 A
申请人: GUANGDONG SAIBO TECH CO LTD
优先权: 2017
CN
第 1 / 5 页
上一页
下一页
药物
反馈